Bausch Health Companies (BHC) Invested Capital (2009 - 2026)

Bausch Health Companies has disclosed Invested Capital across 18 years of filings, most recently posting $18.7 billion for Q1 2026.

• Invested Capital for Q1 2026 came in at $18.7 billion, down 12.06% year-over-year; the trailing twelve-month figure through Mar 2026 was $18.7 billion (down 12.06% YoY), and the FY2025 annual result was $21.2 billion, up 4.21% from the prior year.
• Invested Capital came in at $18.7 billion for Q1 2026 at Bausch Health Companies, down from $21.2 billion in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $23.0 billion in Q1 2022 to a low of $18.7 billion in Q1 2026.
• The 5-year median for Invested Capital is $21.4 billion (2025), against an average of $21.4 billion.
• Across the five-year window, Invested Capital rose 6.09% in 2023 and declined 12.06% in 2026, its largest moves.
• Bausch Health Companies' Invested Capital stood at $21.0 billion in 2022, then gained by 6.09% to $22.3 billion in 2023, then slipped by 8.83% to $20.3 billion in 2024, then rose by 4.21% to $21.2 billion in 2025, then declined by 11.74% to $18.7 billion in 2026.
• The last three Invested Capital figures came in at $18.7 billion (Q1 2026), $21.2 billion (Q4 2025), and $21.4 billion (Q3 2025), per Business Quant data.